コーパス検索結果 (right1)
通し番号をクリックするとPubMedの該当ページを表示します
5 d 1.5-45 year-olds (N=148) into four age-descending groups, randomized 2:1 to receive two doses of TAK-003 or placebo 90
11 DESIGN, SETTING, AND PARTICIPANTS: Open-label, randomized clinical trial conducted at 17 UK hospitals.
13 A subset of patients (n = 116) enrolled in 3 phase-3 randomized clinical trials (AMAGINE -1 [Efficacy, Safety, and
14 one articles were included in this review, of which 12 were randomized clinical trials of therapy that included 3074 pati
15 latrines, sani-scoops, child potties delivered as part of a randomized control trial, WASH Benefits) in rural Bangladeshi
16 n longer-term AVF patency, we performed an observer-blinded randomized controlled trial at three university hospitals in
18 Findings from this exploratory analysis of a randomized controlled trial support further investigation of
24 DESIGN, SETTING, AND PARTICIPANTS: Multicenter randomized double-blind sequential trial conducted in France,
27 Of 169 patients (age range, 4-17 years) initially randomized in the 4-month VErnal KeratoconjunctiviTIs Study (
28 f 151 patients who underwent a major hepatic resection were randomized (mean age = 62.8 years; 57% male; body-mass-index
31 CKD stage G3 or G4 and hypertension, we conducted a 6-week, randomized, open-label crossover trial comparing amiloride/hy
33 As part of the Women's Health Initiative, randomized, placebo-controlled hormone therapy trials of conj
35 inical Trials in Organ Transplantation-09 study in which we randomized stable kidney transplant recipients to Tac withdra
36 Healthy adult participants were recruited and randomized to (I) IDA alone, (II) IDA combined with AZI, (III
39 HIV-negative, non-pregnant Rwandan BV patients were randomized to four groups (n = 17/group) after seven-day oral
40 allel-group, double-blind clinical trial, participants were randomized to receive either 150 mg/d of resveratrol (n = 20)
41 e-blinded trial, 444 adults 60 through 64 years of age were randomized to receive either a single dose of PCV20 followed
43 These conclusions should be confirmed in a prospective randomized trial before firm recommendations regarding clinic
45 not on oral anticoagulation enrolled in the Evolut Low Risk randomized trial underwent computed tomographic imaging 30 da